- Intrahepatic cholangiocarcinoma: histological diversity and the role of the pathologist
-
Komuta M
- KMID: 2553814
- J Liver Cancer.
- 2024 Mar;24(1):17-22.
- doi: 10.17998/jlc.2023.12.11
Intrahepatic cholangiocarcinoma (iCCA) is one of the primary liver cancers and presents with tumor heterogeneity. About 50% of iCCAs comprise actionable mutations, which completely change patient management. In addition, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
-
Komuta M
- KMID: 2531367
- Clin Mol Hepatol.
- 2022 Jul;28(3):396-407.
- doi: 10.3350/cmh.2021.0287
Treatment of intrahepatic cholangiocarcinoma (iCCA) is currently at a significant turning point due to the identification of isocitrate dehydrogenase (IDH) mutations and fibroblast growth factor receptor (FGFR) fusions that can... -
- CITED
-
- Close
- SHARE
-
- Close
